Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

Codexis (CDXS)

Codexis Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CDXS
DateTimeSourceHeadlineSymbolCompany
20/05/202421:05GlobeNewswire Inc.Codexis to Participate in TD Cowen 2nd Annual Sustainability WeekNASDAQ:CDXSCodexis Inc
14/05/202414:11Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CDXSCodexis Inc
14/05/202411:52Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
14/05/202411:00GlobeNewswire Inc.Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual MeetingNASDAQ:CDXSCodexis Inc
02/05/202421:05GlobeNewswire Inc.Codexis Reports First Quarter 2024 Financial ResultsNASDAQ:CDXSCodexis Inc
18/04/202421:05GlobeNewswire Inc.Codexis to Report First Quarter 2024 Financial Results on May 2NASDAQ:CDXSCodexis Inc
11/04/202412:05GlobeNewswire Inc.Codexis Appoints Carole Cobb, MBA, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
06/03/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
28/02/202421:05GlobeNewswire Inc.Codexis Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:CDXSCodexis Inc
27/02/202417:15AllPennyStocks.comBiotech Rallied Strongly On Exclusive Licensing AgreementNASDAQ:CDXSCodexis Inc
26/02/202421:05GlobeNewswire Inc.Codexis Enters Exclusive Licensing Agreement for Newly Engineered Double-Stranded DNA Ligase with RocheNASDAQ:CDXSCodexis Inc
26/02/202413:05GlobeNewswire Inc.Codexis to Participate in TD Cowen 44th Annual Health Care ConferenceNASDAQ:CDXSCodexis Inc
20/02/202413:05GlobeNewswire Inc.Codexis Announces Appointment of Masad Damha, PhD, and Jim Lalonde, PhD, to Strategic Advisory BoardNASDAQ:CDXSCodexis Inc
16/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
14/02/202421:51Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
14/02/202421:05GlobeNewswire Inc.Codexis to Report Fourth Quarter and Fiscal Year 2023 Financial Results on February 28NASDAQ:CDXSCodexis Inc
13/02/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
13/02/202421:05GlobeNewswire Inc.Codexis Secures $40 Million in Strategic Financing Deal with Innovatus Capital Partners to Further Strengthen Cash Position Ahead of Key MilestonesNASDAQ:CDXSCodexis Inc
09/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
01/02/202421:05GlobeNewswire Inc.seqWell and Codexis to Unveil Engineered Transposase Enzyme for Genomics Applications at AGBT General MeetingNASDAQ:CDXSCodexis Inc
24/01/202419:27Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:CDXSCodexis Inc
09/01/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
03/01/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
03/01/202402:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
03/01/202402:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
03/01/202402:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CDXSCodexis Inc
27/12/202313:30GlobeNewswire Inc.Codexis Announces Purchase Agreement with Nestlé Health Science for CDX-7108NASDAQ:CDXSCodexis Inc
27/12/202313:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CDXSCodexis Inc
13/12/202321:06GlobeNewswire Inc.Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseNASDAQ:CDXSCodexis Inc
13/12/202321:05GlobeNewswire Inc.Codexis Announces Achievement of Gram-scale Synthesis with its ECO Synthesis™ PlatformNASDAQ:CDXSCodexis Inc
 Showing the most relevant articles for your search:NASDAQ:CDXS